JNJ Earnings
Latest Revenue25.3B
Latest Net Income5.5B
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $2.30 | 25.3B | 5.5B | +6.6% | +0.0% |
| Q1 2026 | $2.17 | 24.1B | 5.2B | +9.9% | -52.5% |
| Q4 2025 | $2.12 | 24.6B | 5.1B | +9.1% | +48.3% |
| Q3 2025 | $2.14 | 24.0B | 5.2B | +6.8% | +91.1% |
| Q2 2025 | $2.30 | 23.7B | 5.5B | +5.8% | +17.9% |
| Q1 2025 | $4.57 | 21.9B | 11.0B | +2.4% | +238.5% |
| Q4 2024 | $1.43 | 22.5B | 3.4B | +5.3% | -14.9% |
| Q3 2024 | $1.12 | 22.5B | 2.7B | +5.2% | -89.1% |
| Q2 2024 | $1.95 | 22.4B | 4.7B | — | — |
| Q1 2024 | $1.35 | 21.4B | 3.3B | — | — |
| Q4 2023 | $1.68 | 21.4B | 4.0B | — | — |
| Q3 2023 | $10.32 | 21.4B | 26.0B | — | — |
Johnson & Johnson (JNJ) — Earnings